Sun Pharma Q4 Results 2025: The pharma company reported a downgrade in its PAT in the Q4 results declared on 22nd May 2025. Sun Pharma Limited clocked a total revenue from operations of ₹12,958.8 crores, up 8.14% YoY. The company’s PAT for the period under review dipped significantly by 19% to ₹2,1539.93 crore, compared with the PAT of Q4 FY24. However, even after a decreased profit, Sun Pharma has declared a final dividend of ₹5.50 per share for FY25. 

Sun Pharma Q4 Results 2025: Extracts of Q4 FY25 and FY25 Financials

*Figures in crores except EPS

Sun Pharma Q4 Results 2025 Highlights: Consolidated Figures

1. Sun Pharma Limited clocked a total revenue from operations of ₹12,958.84 crores, 8% YoY up in Q4 FY25. During the full fiscal year 2025, the company’s revenue stood at ₹52,578.44 crores. 
2. On the profit front, the company took a hit of 19% quarterly. However, Sun Pharma registered a growth of more than 10% in its full-year PAT figures. 
3. The company’s EPS (basic and diluted) for Q4 FY25 stood at 9.0 against 11.1 in Q4 FY24. 
4. The PBT of Sun Pharma Limited increased by 15.58% in Q4 FY25 to ₹3,254.35 crores. 

Sun Pharma Limited Share Price Performance

Sun Pharma shares opened with a loss of 3.53% at a level of ₹1,658.00 on 23rd May 2025. This opening dip can be associated with a negative investor sentiment due to weak Q4 profits. During the intraday trading, the company’s share price touched a day high of ₹1,689.50, still lower than the previous closing of ₹1,718.70.  On the closing bell on 23rd May 2025, Sun Pharma shares closed at a level of ₹1,689.10, 1.72% lower.

For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities. 

Recent News Articles

Unified Data Tech IPO GMP: Day 1 IPO Live Updates

Stock Market Today: Sensex Plunged 800 Points & Nifty50 By 0.9%; Check Key Insights

Best Semiconductor Stocks in India 2025 

Unified Data- Tech IPO Review: Know GMP and other IPO Details; Should You Apply or Not? 

United Spirits Q4 Results 2025: Net Profit Grows to ₹421 Crores and EBITDA Climbs by 37.7%.

Stock Market Today: Sensex Soar 119 Points & Nifty50 By 0.09%; Check Key Insights

Hindalco Q4 Results 2025 Declared 66% Rise in Profit and 16% Surge in Revenue: Check Key Highlights

Stocks to Watch Today: 21st May 2025 | Dixon, GSFC, United Spirits, IRCON, Zaggle, & More!

Zydus Lifesciences Q4 Results 2025 Declared 1% Dip in Profit and Dividend of ₹11 Per Share: Check Key Highlights

Victory Electric IPO GMP: Day 1 IPO Live Updates